Spotlight -

Concierge Medicine Forum|

Practice Finance

CME Content

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Please check back later for more content.

Trending on Medical Economics

59% of health care workers plan to look for a new job in the next year, Harris Poll finds

Your employees think your recognition effort stinks

U.S. Preventive Services Task Force roster adds new cardiologists, radiologist, health economist

AI models flag existing drugs that could fight drug-resistant pneumonia bacteria

AI scribes cut documentation time by 69% in simulated primary care visits, study finds